Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Biolog Announces Appointment of Distributors in Europe

Published: Thursday, September 27, 2012
Last Updated: Thursday, September 27, 2012
Bookmark and Share
New distributors to cover sales and marketing of Biolog’s innovative product lines.

New distributors were announced by Biolog, Inc. to cover sales and marketing of its innovative product lines for characterization and identification of diverse cell types, from bacteria to human cells.

The distributors and their respective territories are IUL Instruments GmbH, Koningswinter, Germany (Germany and Austria), Awel International, Blain, France (France), A&LCO Industries, Cologno, Italy (Italy), and IUL S.A., Barcelona, Spain (Spain).

According to Barry Bochner, CEO & CSO at Biolog, "The distributors were selected as being most qualified to provide local supply, technical and service support to our customers in these countries."

Biolog's flagship product is the GEN III MicroPlate™, a test panel that can be used for identifying over 1,300 species of bacteria and covering human pathogens, animal pathogens, plant pathogens, and typical environmental bacteria.

Phenotype MicroArrays™, the company's most advanced product line, have diverse applications ranging from basic genetic and cellular research to cancer studies, drug and toxicology studies, and bioprocess optimization.

Biolog's product lines also include advanced instrumented systems such as the OmniLog® and MicroStation™ that automatically read and help to interpret the phenotypic data that is generated.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,700+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biolog’s PM Technology Unlocks Critical Clue in Understanding Autism
Discovery demonstrates advantage of metabolic over genetic screening.
Friday, June 07, 2013
Scientific News
Four New Genetic Disorders Identified
Sharing of genetic data empowers discovery of new disorders in children.
Biomarker Predicting Transplant Complications May be Key to Treating Them
A protein that can be used to predict if a stem cell transplant patient will suffer severe complications may also be the key to preventing those complications, an international research team based at the Indiana University School of Medicine reported Wednesday.
Potential New Diagnosis and Therapy for Breast Cancer
Scientists at the University of York, using clinical specimens from charity Breast Cancer Now’s Tissue Bank, have conducted new research into a specific sodium channel that indicates the presence of cancer cells and affects tumour growth rates.
Enzyme Malfunction May be Why Binge Drinking Can Lead to Alcoholism
A new study in mice shows that restoring the synthesis of a key brain chemical tied to inhibiting addictive behavior may help prevent alcohol cravings following binge drinking.
Cell's Waste Disposal System Regulates Body Clock Proteins
New way to identify interacting proteins could identify potential drug targets.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
Promising Drug Candidate to Treat Chronic Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) describe a class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,700+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos